» Articles » PMID: 22193671

The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings from Three Multisite Studies with Adolescents and Adults

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 2011 Dec 24
PMID 22193671
Citations 1682
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Research on suicide prevention and interventions requires a standard method for assessing both suicidal ideation and behavior to identify those at risk and to track treatment response. The Columbia-Suicide Severity Rating Scale (C-SSRS) was designed to quantify the severity of suicidal ideation and behavior. The authors examined the psychometric properties of the scale.

Method: The C-SSRS's validity relative to other measures of suicidal ideation and behavior and the internal consistency of its intensity of ideation subscale were analyzed in three multisite studies: a treatment study of adolescent suicide attempters (N=124); a medication efficacy trial with depressed adolescents (N=312); and a study of adults presenting to an emergency department for psychiatric reasons (N=237).

Results: The C-SSRS demonstrated good convergent and divergent validity with other multi-informant suicidal ideation and behavior scales and had high sensitivity and specificity for suicidal behavior classifications compared with another behavior scale and an independent suicide evaluation board. Both the ideation and behavior subscales were sensitive to change over time. The intensity of ideation subscale demonstrated moderate to strong internal consistency. In the adolescent suicide attempters study, worst-point lifetime suicidal ideation on the C-SSRS predicted suicide attempts during the study, whereas the Scale for Suicide Ideation did not. Participants with the two highest levels of ideation severity (intent or intent with plan) at baseline had higher odds for attempting suicide during the study.

Conclusions: These findings suggest that the C-SSRS is suitable for assessment of suicidal ideation and behavior in clinical and research settings.

Citing Articles

Validation and cultural adaptation of the Persian version of the suicidal ideation attributes scale (SIDAS).

Tehrani H, Jafari A, Gholamzadeh M, Babaei K, Nejatian M, Naddafi F BMC Public Health. 2025; 25(1):972.

PMID: 40075304 PMC: 11899323. DOI: 10.1186/s12889-025-22113-8.


Association between serum oxidative stress indicators, inflammatory indicators and suicide attempts in adolescents with major depressive disorder.

Peng C, Xu M, Ye M, Yang W, Fang M Front Psychiatry. 2025; 16:1539158.

PMID: 40066132 PMC: 11891218. DOI: 10.3389/fpsyt.2025.1539158.


Investigating the impact of electroconvulsive therapy on brain networks and sleep: an observational study protocol.

Kafashan M, Lebovitz L, Greenspan R, Zhao S, Kim T, Husain M BMJ Open. 2025; 15(3):e098859.

PMID: 40054874 PMC: 11891538. DOI: 10.1136/bmjopen-2025-098859.


Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development.

Weintraub M, Jeffrey J, Grob C, Ichinose M, Bergman R, Cooper Z Psychedelic Med (New Rochelle). 2025; 1(4):230-240.

PMID: 40046861 PMC: 11658652. DOI: 10.1089/psymed.2023.0018.


Development of the Mobile Application to Prevent Suicide (MAPS), a Personalized Smartphone App for Suicide Prevention: Feedback from Individual Interviews.

Schatten H, Kimble S, Alboukrek D, Carosa C, Hughes C, Armey M J Technol Hum Serv. 2025; 42(2):156-172.

PMID: 40028236 PMC: 11870380. DOI: 10.1080/15228835.2024.2351416.


References
1.
Zimmerman M, Chelminski I, Posternak M . Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J Nerv Ment Dis. 2004; 192(2):87-94. DOI: 10.1097/01.nmd.0000110279.23893.82. View

2.
Joiner Jr T, Steer R, Brown G, Beck A, Pettit J, Rudd M . Worst-point suicidal plans: a dimension of suicidality predictive of past suicide attempts and eventual death by suicide. Behav Res Ther. 2003; 41(12):1469-80. DOI: 10.1016/s0005-7967(03)00070-6. View

3.
Emslie G, Ventura D, Korotzer A, Tourkodimitris S . Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009; 48(7):721-729. DOI: 10.1097/CHI.0b013e3181a2b304. View

4.
Beck A, Brown G, Steer R . Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther. 1998; 35(11):1039-46. DOI: 10.1016/s0005-7967(97)00073-9. View

5.
Brent D . The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step. Depress Anxiety. 2009; 26(10):871-4. PMC: 4083507. DOI: 10.1002/da.20617. View